Early drug forming screening
The early drug formation of compounds can be studied through toxicity prediction, pharmacokinetic screening, and efficacy screening studies, including cardiac toxicity risk prediction, tolerance dose of related species, bioavailability, cytotoxicity, and genotoxicity.
■ Cardiovascular safety screening test (Non GLP): hERG patch clamp
■ Tolerance exploration: rats, mice, dogs, monkeys
■ Cytotoxicity screening study
■ Genotoxicity screening study
■ Cardiovascular safety screening test (Non GLP): hERG patch clamp
■ Tolerance exploration: rats, mice, dogs, monkeys
■ Cytotoxicity screening study
■ Genotoxicity screening study
